Today: 9 June 2026
Circle (CRCL) stock slips into year-end close as Fed minutes keep rate bets in focus
31 December 2025
2 mins read

Circle (CRCL) stock slips into year-end close as Fed minutes keep rate bets in focus

NEW YORK, December 30, 2025, 20:36 ET — Market closed

  • Circle shares closed at $79.89, down about 0.7%, after swinging between $79.68 and $82.88.
  • Investors are weighing the Fed’s rate outlook against stablecoin growth, a key driver of Circle’s reserve income.
  • Bitcoin rose about 0.7% on the day, keeping crypto-linked stocks in focus into the final U.S. session of 2025.

Circle Internet Group shares ended lower on Tuesday, closing at $79.89 as U.S. stocks eased in holiday-thin trading. The USDC stablecoin issuer traded between $79.68 and $82.88.

The stock’s sensitivity to interest rates is front and center heading into year-end. Circle’s core earnings power is tied to yield on cash and short-dated government assets backing USDC, a type of cryptocurrency designed to hold a steady $1 value.

That makes the Federal Reserve’s policy path a near-term driver as investors debate how quickly borrowing costs may fall in 2026. Minutes from the Fed’s latest meeting underscored divisions on the outlook, Reuters reported.

U.S. stocks slipped modestly on Tuesday, while bitcoin rose 0.74% to $87,888.55, Reuters data showed. Risk appetite in crypto and the direction of yields often feed into trading in companies tied to digital-asset activity.

Other crypto-linked names were mixed late Tuesday. Coinbase fell about 0.9%, while Strategy was little changed.

Circle’s own daily metrics remain a key watch for investors trying to handicap revenue momentum. The company’s website showed USDC in circulation at $75.9 billion as of Dec. 29.

Circle says USDC reserves are held in highly liquid assets, with the majority of the reserve in the Circle Reserve Fund (USDXX), an SEC-registered 2a-7 government money market fund managed by BlackRock. Those portfolios typically hold cash, short-dated U.S. Treasuries and overnight Treasury repurchase agreements.

For traders, the setup is straightforward: softer yields can squeeze the interest income Circle earns on reserves, while growth in USDC supply can expand the base those yields apply to. The Fed minutes kept both sides of that equation in play late Tuesday.

Before Wednesday’s final U.S. trading session of 2025, investors will watch Treasury yields and crypto prices for cues on positioning into the New Year holiday. Reuters described Tuesday’s session as light-volume and pre-holiday.

“Solid corporate profits can make up for a lot of sins,” Ryan Detrick, chief market strategist at Carson Group, told Reuters in a broader year-end markets recap. For Circle, investors are looking for evidence that USDC growth and take-up beyond crypto trading can keep earnings resilient as the rate cycle turns. Reuters

Technically, $80 is the near-term line traders are watching after Tuesday’s dip, with the day’s low around $79.68 and resistance near $83, close to Tuesday’s intraday high.

The next major company-specific catalyst is Circle’s next quarterly update. The latest earnings call posted on Circle’s investor relations site was for Nov. 12.

With U.S. markets shut on New Year’s Day and crypto trading around the clock, any sharp moves in bitcoin, stablecoin flows, or rate expectations are likely to show up first in extended-hours pricing — and then in Circle’s next regular-session open.

Stock Market Today

  • Soybean Prices Decline Amid Lower Export Shipments and Reduced Speculative Positions
    June 9, 2026, 9:21 AM EDT. Soybean prices fell between 2 and 5 ½ cents on Monday, with the national average cash price dropping to $10.58 3/4 per bushel. Export shipments for the week ending June 4 decreased by 21.2% from the previous week, totaling 398,186 MT, and are down 28.8% year-over-year. Key buyers included Egypt, China, and Mexico. Marketing year exports stand 20.3% lower compared to last year. Meanwhile, speculative traders reduced their net long positions in soybean futures and options by 33,502 contracts, signaling cautious market sentiment. Soymeal and soy oil futures also declined modestly. A private export sale of 264,000 MT was reported for the 2026/27 season, but overall market pressure weighs on prices going into the week.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop